Raman Preet Kaur
Overview
Explore the profile of Raman Preet Kaur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lechner M, Takahashi Y, Turri-Zanoni M, Ferrari M, Liu J, Counsell N, et al.
J Neurol Surg B Skull Base
. 2023 Jul;
84(4):307-319.
PMID: 37405239
Sinonasal mucosal melanoma (SNMM) is an extremely rare and challenging sinonasal malignancy with a poor prognosis. Standard treatment involves complete surgical resection, but the role of adjuvant therapy remains unclear....
2.
Lechner M, Takahashi Y, Turri-Zanoni M, Liu J, Counsell N, Hermsen M, et al.
Eur J Cancer
. 2022 Jan;
162:221-236.
PMID: 34980502
Introduction: Olfactory neuroblastoma (ONB) is a rare cancer of the sinonasal region. We provide a comprehensive analysis of this malignancy with molecular and clinical trial data on a subset of...
3.
Kaur R, Izumchenko E, Blakaj D, Mladkova N, Lechner M, Beaumont T, et al.
Laryngoscope Investig Otolaryngol
. 2021 Aug;
6(4):721-728.
PMID: 34401496
Background: Olfactory neuroblastoma (ONB) or esthesioneuroblastoma (ENB) is a rare malignancy of the nasal cavity believed to arise from the olfactory epithelium. The goal of this study was to systematically...
4.
Kaur R, Kumar V, Shafi G, Vashistha R, Kulharia M, Munshi A
Med Oncol
. 2019 Jun;
36(8):70.
PMID: 31203460
Alterations in BRCA2, PALB2, CHEK2, and p53 genes have been identified for their association with male breast cancer in various studies. The incidence of male breast cancer in India is...
5.
Singla H, Kaur R, Shafi G, Vashistha R, Banipal R, Kumar V, et al.
Mol Biol Rep
. 2018 Dec;
46(1):823-831.
PMID: 30535550
Human epidermal growth factor receptor 2 positive (HER2+) breast cancer (BC) is an aggressive BC subtype characterized by HER2 overexpression/amplification. Genomic alterations of HER2 and others have been reported to...
6.
Kaur R, Vasudeva K, Kumar R, Munshi A
Curr Pharm Des
. 2018 Sep;
24(30):3566-3575.
PMID: 30255744
TP53 is a tumor suppressor gene which is commonly mutated in various cancers including breast cancer. Alterations in the gene lead to an altered expression of various genes that are...
7.
Kaur R, Vasudeva K, Singla H, Benipal R, Khetarpal P, Munshi A
J Cell Physiol
. 2018 Aug;
233(12):9716-9723.
PMID: 30078181
The aim of current study was to evaluate the genetic variation in all the genes encoding pro- and anti-inflammatory cytokines in association with breast cancer development in patients from Malwa...
8.
Kalra S, Kaur R, Ludhiadch A, Shafi G, Vashista R, Kumar R, et al.
Eur J Clin Pharmacol
. 2018 Jun;
74(10):1291-1298.
PMID: 29938344
Purpose: Cyclophosphamide and doxorubicin (adjuvant chemotherapy) are commonly used to treat breast cancer patients. Variation in the genes involved in pharmacodynamics and pharmacokinetics of these drugs plays an important role...
9.
Kaur R, Rubal , Banipal R, Vashistha R, Dhiman M, Munshi A
Curr Probl Cancer
. 2018 Jun;
43(2):123-129.
PMID: 29921457
Background And Purpose: Inflammation and caner are linked in a bidirectional manner. C-reactive protein (CRP) is an important inflammatory marker. The aim of the study was to test whether the...
10.
Kaur R, Shafi G, Benipal R, Munshi A
Med Oncol
. 2018 Apr;
35(6):81.
PMID: 29700634
In this study, we evaluated the incidence of pathogenic germline mutations in 30 breast cancer susceptibility genes in breast cancer patients. Our aim was to understand the involvement of the...